Calendario de promoción ASLAN Pharmaceuticals Limited
Horario avanzado
gráfico sencillo
Acerca de la empresa ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal antibody that targets the IL-13 receptor a1 subunit which is being developed for the treatment of atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune diseases. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co. más detalles| IPO date | 2018-05-04 |
|---|---|
| ISIN | US04522R1014 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://aslanpharma.com |
| Цена ао | 0.6 |
| Cambio de precio por día: | 0% (0.6) |
|---|---|
| Cambio de precio por semana.: | 0% (0.6) |
| Cambio de precio por mes: | 0% (0.6) |
| Cambio de precio en 3 meses.: | 0% (0.6) |
| Cambio de precio en seis meses: | 0% (0.6) |
| Cambio de precio por año: | -4% (0.625) |
| Cambio de precio en 3 años.: | -22.67% (0.7759) |
| Cambio de precio en 5 años.: | -72.09% (2.15) |
| Cambio de precio en 10 años.: | 0% (0.6) |
| Cambio de precio desde principios de año.: | 0% (0.6) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| BVF Inc. | 1049999 | 13.82 |
| UBS Group AG | 625000 | 8.23 |
| Citadel Advisors Llc | 482963 | 6.36 |
| Shay Capital LLC | 400000 | 5.26 |
| Sio Capital Management, LLC | 254150 | 3.34 |
| Renaissance Technologies, LLC | 172801 | 2.27 |
| Parkman Healthcare Partners LLC | 110658 | 1.46 |
| Landscape Capital Management LLC | 83259 | 1.1 |
| Millennium Management LLC | 80362 | 1.06 |
| Waterfront Wealth, Inc. | 40941 | 0.54 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Dr. Carl Alan Jason Morton Firth EMBA, Ph.D. | Founder, CEO & Executive Director | N/A | 1973 (52 año) |
| Mr. Kiran Kumar Asarpota | COO & Head of Finance | N/A | 1979 (46 años) |
| Mr. Ben Goodger | General Counsel | N/A | 1963 (62 año) |
| Mr. Stephen Doyle | Chief Business Officer | N/A | 1973 (52 año) |
| Dr. Alexandre Kaoukhov M.D. | Chief Medical Officer | N/A | 1974 (51 año) |
| Charlie Hsu | Investor Relations Director | N/A | |
| Chi-Chin Wang | IR & Corporate Development Director | N/A |
DIRECCIÓN: Singapore, Singapore, 3 Temasek Avenue - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://aslanpharma.com
Sitio web: https://aslanpharma.com
